Quick Takeaways
- CVI Investments, Inc. filed SCHEDULE 13G for Plus Therapeutics, Inc. Common Stock, $0.001 par value per share (PSTV).
- Disclosed ownership: 6.9%.
- Date of event: 14 Jan 2026.
CVI Investments, Inc. - 14 Jan 2026 SCHEDULE 13G Report for Plus Therapeutics, Inc. Common Stock, $0.001 par value per share (PSTV)
- Filing Manager
- CVI Investments, Inc.
- Reporting Manager
- CVI Investments, Inc.
- Symbol
- PSTV
- Shares outstanding
- 179,252,507 shares
- Disclosed Ownership
- 12,368,423 shares
- Ownership
- 6.9%
- Form type
- SCHEDULE 13G
- Filing time
- 22 Jan 2026, 10:02:26 UTC
- Date of event
- 14 Jan 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"CVI Investments, Inc. disclosed 6.9% ownership in Plus Therapeutics, Inc. Common Stock, $0.001 par value per share (PSTV) on 14 Jan 2026."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 22 Jan 2026, 10:02.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| CVI Investments, Inc. | 6.9% | 12,368,423 | 0 | 12,368,423 | /s/ Sarah Travis | Sarah Travis, Assistant General Counsel and Assistant Secretary of Heights Capital Management, Inc. | |
| Heights Capital Management, Inc. | 6.9% | 12,368,423 | 0 | 12,368,423 | /s/ Sarah Travis | Sarah Travis, Assistant General Counsel and Assistant Secretary |